Sort
15,842 grants matching “pancreatic cancer”
Core 2: Biospecimen/Pathology Core
$129,282Elizabeth D Thompson · Johns Hopkins University · P50 · FY2022 · CA
Core 2: Biospecimen/Pathology Core
$129,281Robert A Anders · Johns Hopkins University · P50 · FY2019 · CA
Precision Management of Cystic Precursors to Pancreatic Cancer
$129,205Pari Vijay Pandharipande · Ohio State University · R01 · FY2021 · CA
Stromal depletion for pancreatic cancer therapy
$129,195Shyh-Dar Li · Ontario Institute For Cancer Research · R21 · FY2013 · CA
Training the Next Generation of Surgeon-Scientists in Pancreatology
$129,188Masato Yamamoto · University Of Minnesota · T32 · FY2024 · DK
Mouse model of adult-onset, isolated, GH-deficiency
$129,150Rhonda D. Kineman · University Of Illinois At Chicago · R21 · FY2009 · AG
Cellular mechanisms and therapeutic possibilities of inhibiting oncogenic KRAS
$129,145Andrew L Wolfe · University Of California, San Francisco · K99 · FY2020 · CA
Measuring and manipulating metabolic fluxes in the tumor microenvironment
$128,990Caroline Bartman · Princeton University · K99 · FY2022 · CA
Diversity Supplement to R01 Parent Grant CA186885
$128,725Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2016 · CA
Administration and Communication
$128,645Scott E Kern · Johns Hopkins University · P50 · FY2013 · CA
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis
$128,371Joao A Paulo · Harvard Medical School · K01 · FY2013 · DK
Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
$128,358Jeffrey Zwicker · Beth Israel Deaconess Medical Center · K23 · FY2007 · HL
Engineering protein-specific proteases: targeting signaling proteins
$128,330John Orban · Univ Of Maryland, College Park · R01 · FY2024 · GM
DECODING METABOLIC PROGRAMS UNDERLYING PANCREATIC CANCER PROGRESSION
$128,250The General Hospital Corporation · · FY2016 · Department of Defense
Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer
$128,235Dannielle Engle · Cold Spring Harbor Laboratory · K99 · FY2016 · CA
Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer
$128,235Dannielle Engle · Cold Spring Harbor Laboratory · K99 · FY2017 · CA
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors
$128,113Ningling Kang · Mayo Clinic Rochester · K01 · FY2007 · CA
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers
$128,024Suresh T. Chari · Mayo Clinic Rochester · P50 · FY2013 · CA
P-4: Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site
$128,024Pinku Mukherjee · Mayo Clinic Rochester · P50 · FY2013 · CA
P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B
$128,024Daniel D Billadeau · Mayo Clinic Rochester · P50 · FY2013 · CA
Targeting aspartate biosynthesis in pancreatic tumors
$127,990Javier Garcia Bermudez · Rockefeller University · K99 · FY2020 · CA
Administrative Supplement (NoD)
$127,845Christopher E Forsmark · University Of Florida · U01 · FY2019 · DK
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis
$127,831Joao A Paulo · Harvard Medical School · K01 · FY2015 · DK
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis
$127,831Joao A Paulo · Harvard Medical School · K01 · FY2014 · DK
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
$127,680Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2022 · CA